Peripartum Blood Transfusions are Associated with Increased Risk of Cancer: A National Retrospective Cohort Study

References

• Callaghan WM, Creanga AA, Kuklina EV. Severe maternal morbidity among delivery and postpartum hospitalizations in the United States. Obstet Gynecol. 2012;120(5):1029–1036. doi:10.1097/AOG.0b013e31826d60c523090519
   PubMed Web of Science ®Google Scholar
• Callaghan WM, Kuklina EV, Berg CJ. Trends in postpartum hemorrhage: United States, 1994–2006. Am J Obstet Gynecol. 2010;202(4):353e1–6. doi:10.1016/j.ajog.2010.01.01120350642
   PubMed Web of Science ®Google Scholar
• Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood. 2009;113(15):3406–3417. doi:10.1182/blood-2008-10-16764319188662
   PubMed Web of Science ®Google Scholar
• Dwyre DM, Fernando LP, Holland PV. Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century. Vox Sang. 2011;100(1):92–98. doi:10.1111/j.1423-0410.2010.01426.x21175659
   PubMed Web of Science ®Google Scholar
• Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev. 2007;21(6):327–348. doi:10.1016/j.blre.2007.07.00317804128
   PubMed Web of Science ®Google Scholar
• Brand A. Immunological aspects of blood transfusions. Transpl Immunol. 2002;10(2–3):183–190. doi:10.1016/S0966-3274(02)00064-312216948
   PubMed Web of Science ®Google Scholar
• Cata JP, Wang H, Gottumukkala V, Reuben J, Sessler DI. Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anaesth. 2013;110(5):690–701. doi:10.1093/bja/aet06823599512
   PubMed Web of Science ®Google Scholar
• Kirkley SA, Cowles J, Pellegrini VD, Harris CM, Boyd AD, Blumberg N. Blood transfusion and total joint replacement surgery: T helper 2 (TH2) cytokine secretion and clinical outcome. Transfus Med. 1998;8(3):195–204. doi:10.1046/j.1365-3148.1998.00149.x9800291
   PubMed Web of Science ®Google Scholar
• Innerhofer P, Luz G, Spotl L, et al. Immunologic changes after transfusion of autologous or allogeneic buffy coat-poor versus white cell-reduced blood to patients undergoing arthroplasty. I. Proliferative T-cell responses and the balance of helper and suppressor T cells. Transfusion. 1999;39(10):1089–1096. doi:10.1046/j.1537-2995.1999.39101089.x10532603
   PubMed Web of Science ®Google Scholar
• Landers DF, Hill GE, Wong KC, Fox IJ. Blood transfusion-induced immunomodulation. Anesth Analg. 1996;82(1):187–204. doi:10.1097/00000539-199601000-000358712400
   PubMed Web of Science ®Google Scholar
• Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12(4):252–264. doi:10.1038/nrc323922437870
   PubMed Web of Science ®Google Scholar
• Buddeberg F, Schimmer BB, Spahn DR. Transfusion-transmissible infections and transfusion-related immunomodulation. Best Pract Res Clin Anaesthesiol. 2008;22(3):503–517. doi:10.1016/j.bpa.2008.05.00318831300
   PubMedGoogle Scholar
• Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The retrovirus epidemiology donor study. N Engl J Med. 1996;334(26):1685–1690. doi:10.1056/NEJM1996062733426018637512
   PubMed Web of Science ®Google Scholar
• Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev. 2006;1:CD005033.
   Google Scholar
• Busch OR, Hop WC, Marquet RL, Jeekel J. Blood transfusions and local tumor recurrence in colorectal cancer. Evidence of a noncausal relationship. Ann Surg. 1994;220(6):791–797. doi:10.1097/00000658-199412000-000137986147
   PubMed Web of Science ®Google Scholar
• Riedl R, Engels EA, Warren JL, Berghold A, Ricker W, Pfeiffer RM. Blood transfusions and the subsequent risk of cancers in the United States elderly. Transfusion. 2013;53(10):2198–2206. doi:10.1111/trf.1207123320915
   PubMed Web of Science ®Google Scholar
• Yang TO, Cairns BJ, Reeves GK, Green J, Beral V. Million women study c. Cancer risk among 21st century blood transfusion recipients. Ann Oncol. 2017;28(2):393–399. doi:10.1093/annonc/mdw55528426101
   PubMed Web of Science ®Google Scholar
• Hjalgrim H, Edgren G, Rostgaard K, et al. Cancer incidence in blood transfusion recipients. J Natl Cancer Inst. 2007;99(24):1864–1874. doi:10.1093/jnci/djm24818073377
   PubMedGoogle Scholar
• Song SO, Jung CH, Song YD, et al. Background and data configuration process of a nationwide population-based study using the korean national health insurance system. Diabetes Metab J. 2014;38(5):395–403. doi:10.4093/dmj.2014.38.5.39525349827
   PubMedGoogle Scholar
• Shin DW, Cho B, Guallar E. Korean national health insurance database. JAMA Intern Med. 2016;176(1):138. doi:10.1001/jamainternmed.2015.7110
   PubMed Web of Science ®Google Scholar
• Kim H, Lee S, Lim W. Knowing is not half the battle: impacts of the national health screening program in Korea. IZA Discuss Pap. 2017;10650.
   Google Scholar
• Kim MK, Lee WY, Kang JH, et al. 2014 clinical practice guidelines for overweight and obesity in Korea. Endocrinol Metab. 2014;29(4):405–409. doi:10.3803/EnM.2014.29.4.405
   Google Scholar
• Patterson JA, Roberts CL, Bowen JR, et al. Blood transfusion during pregnancy, birth, and the postnatal period. Obstet Gynecol. 2014;123(1):126–133. doi:10.1097/AOG.000000000000005424463672
   PubMed Web of Science ®Google Scholar
• Skanberg J, Frisk B. Blood transfusion does not influence the development of malignant tumours. Eur J Surg. 1999;165(6):528–534. doi:10.1080/11024159975000640610433134
   PubMedGoogle Scholar
• Reshetnyak VI, Karlovich TI, Ilchenko LU. Hepatitis G virus. World J Gastroenterol. 2008;14(30):4725. doi:10.3748/wjg.14.472518720531
   PubMed Web of Science ®Google Scholar
• MacKie RM, Reid R, Junor B. Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. N Engl J Med. 2003;348(6):567–568. doi:10.1056/NEJM20030206348062012571271
   PubMed Web of Science ®Google Scholar
• Edgren G, Hjalgrim H, Reilly M, et al. Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study. Lancet. 2007;369(9574):1724–1730. doi:10.1016/S0140-6736(07)60779-X17512857
   PubMed Web of Science ®Google Scholar
• Blumberg N, Heal JM. Immunomodulation by blood transfusion: an evolving scientific and clinical challenge. Am J Med. 1996;101(3):299–308. doi:10.1016/S0002-9343(96)00124-68873492
   PubMed Web of Science ®Google Scholar
• Brunson ME, Alexander JW. Mechanisms of transfusion-induced immunosuppression. Transfusion. 1990;30(7):651–658. doi:10.1046/j.1537-2995.1990.30790385527.x2205953
   PubMed Web of Science ®Google Scholar
• Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science. 2011;331(6024):1565–1570. doi:10.1126/science.120348621436444
   PubMed Web of Science ®Google Scholar
• Rizvi NA, Hellmann MD, Snyder A, et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science. 2015;348(6230):124–128. doi:10.1126/science.aaa134825765070
   PubMed Web of Science ®Google Scholar
• Whittemore AS, Harris R, Itnyre J, Halpern J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. Am J Epidemiol. 1992;136(10):1175–1183. doi:10.1093/oxfordjournals.aje.a1164261476140
   PubMed Web of Science ®Google Scholar
• Ness RB, Grisso JA, Cottreau C, et al. Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer. Epidemiology. 2000;11(2):111–117. doi:10.1097/00001648-200003000-0000611021606
   PubMed Web of Science ®Google Scholar
• Castillo JJ, Dalia S, Pascual SK. Association between red blood cell transfusions and development of non-Hodgkin lymphoma: a meta-analysis of observational studies. Blood. 2010;116(16):2897–2907. doi:10.1182/blood-2010-03-27668320625008
   PubMed Web of Science ®Google Scholar
• Chang CM, Quinlan SC, Warren JL, Engels EA. Blood transfusions and the subsequent risk of hematologic malignancies. Transfusion. 2010;50(10):2249–2257. doi:10.1111/j.1537-2995.2010.02692.x20497517
   PubMed Web of Science ®Google Scholar
• Refaai MA, Blumberg N. Transfusion immunomodulation from a clinical perspective: an update. Expert Rev Hematol. 2013;6(6):653–663. doi:10.1586/17474086.2013.85002624168641
   PubMed Web of Science ®Google Scholar
• Grimshaw K, Sahler J, Spinelli SL, Phipps RP, Blumberg N. New frontiers in transfusion biology: identification and significance of mediators of morbidity and mortality in stored red blood cells. Transfusion. 2011;51(4):874–880. doi:10.1111/j.1537-2995.2011.03095.x21496049
   PubMed Web of Science ®Google Scholar
• Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet. 1996;348(9031):841–845. doi:10.1016/S0140-6736(96)06168-58826808
   PubMed Web of Science ®Google Scholar
• Koo BN, Kwon MA, Kim SH, et al. Korean clinical practice guideline for perioperative red blood cell transfusion from Korean society of anesthesiologists. Korean J Anesthesiol. 2019;72(2):91–118. doi:10.4097/kja.d.18.0032230513567
   PubMed Web of Science ®Google Scholar
• Choi SJ, Kim S, Kim HO, Kwon JR, Lee SW, Shin Y. The status of use of leukoreduced blood products in Korean hospitals. Lab Med Online. 2012;2(4):204–208. doi:10.3343/lmo.2012.2.4.204
   Google Scholar
• Mor G, Aldo P, Alvero AB. The unique immunological and microbial aspects of pregnancy. Nat Rev Immunol. 2017;17(8):469–482. doi:10.1038/nri.2017.6428627518
   PubMed Web of Science ®Google Scholar
• Lee AI, Kaufman RM. Transfusion medicine and the pregnant patient. Hematol Oncol Clin North Am. 2011;25(2):393–413, ix. doi:10.1016/j.hoc.2011.02.00221444037
   PubMed Web of Science ®Google Scholar
• Thurn L, Wikman A, Westgren M, Lindqvist PG. Incidence and risk factors of transfusion reactions in postpartum blood transfusions. Blood Adv. 2019;3(15):2298–2306. doi:10.1182/bloodadvances.201900007431366586
   PubMed Web of Science ®Google Scholar
• Triulzi DJ, Kleinman S, Kakaiya RM, et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion. 2009;49(9):1825–1835. doi:10.1111/j.1537-2995.2009.02206.x19453983
   PubMed Web of Science ®Google Scholar